Are NTRB insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies NTRB leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Stock Ratings / Health Care / NTRB / insiders

CNXU (43) LAKE (26) AGPU (42) APT (61) ⌘ Pro Terminal →

Nutriband Inc. (NTRB) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$6.41 +1.75% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.42

Nutriband Inc. (NTRB) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $76.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NTRB Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $6.41 (+1.75% 1D, market cap $76.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #540 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NTRB compare to CNXU and LAKE in the Health Care sector?

▼

Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M) and LAKE (Lakeland Industries Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NTRB?

▼

Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $6.42 (+0.13%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NTRB)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY NTRB SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (27% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$6.52-10.3% Next Q

Q2 (-2Q)

Grade D$5.85+1.7% Next Q

Q3 (-1Q)

Grade D$5.95+7.7% Next Q

Current

Grade D-$6.41-8.1% Hist 90D α

Trajectory: D (45) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NTRB Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NTRB currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.42) and Max Pain ($6.73) forces dealer call-delta covering toward $9.65.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NTRB• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NTRB Beats Next Quarter EPS Consensus (Jan 30, 2027) & Holds Above 200D SMA”

YES 37%NO 63%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

NTRB Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (NTRB)

No recent open-market Form 4 cluster sales or emergency dumps flagged on NTRB. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NTRB)

✓Walkthrough of NTRB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NTRB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +73.24%📐 HORIZONTAL RANGE

2026-11-03O $6.64H $6.64L $6.30C $6.41VOL 22.2K

RES: $11.00SUP: $2.60SMA50: $6.42SMA200: $4.39

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NTRB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NTRB Butterfly Map → + Track NTRB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -4.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NTRB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NTRB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NTRB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NTRB)

Health Care Rank #540 of 1016 ⚔️ CNXU vs NTRB Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NTRB vs. CNXU, LAKE, AGPU, APT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Nutriband Inc. (NTRB) ranks #540 by composite RQD confidence (37/100, grade D-) and #686 by equity capitalization ($76.6M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with NTRB at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NTRB ACTIVE Nutriband Inc.	D-	37/100	—	27.8%	-35.0%	+1.75%	$76.6M	Benchmark Subject
CNXU Conexeu Sciences Inc.	D-	43/100	—	—	—	-5.51%	$77.0M	/cnxu-vs-ntrb →
LAKE Lakeland Industries Inc.	E	26/100	—	32.9%	-9.5%	+1.82%	$87.3M	/lake-vs-ntrb →
AGPU Axe Compute Inc.	D-	42/100	—	—	-35.0%	-4.87%	$92.7M	/agpu-vs-ntrb →
APT Alpha Pro Tech Ltd.	C-	61/100	16.2x	38.1%	6.7%	+2.22%	$55.1M	/apt-vs-ntrb →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-01-31 • CIK 0001676047

In its most recent audited fiscal period (FY2025, filed 2026-01-31), Nutriband Inc. (NTRB) reported GAAP revenue of $2.0M (-4.8% vs. FY2024 revenue of $2.1M , and -2.3% cumulative change since FY2023) , GAAP net income of -$8.2M, operating cash flow of -$5.1M, and free cash flow of -$5.1M (-8.9% YoY). On the balance sheet, NTRB closed FY2025 with $7.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-01-31	$2.0M	-$8.2M	-$5.1M	-$5.1M	$7.5M	—
FY2024 (FY)	2025-01-31	$2.1M	-$10.5M	-$4.6M	-$4.7M	$7.5M	—
FY2023 (FY)	2024-01-31	$2.1M	-$5.5M	-$3.5M	-$3.5M	—	—

3. NTRB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does NTRB compare to CNXU and LAKE in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for NTRB?

Where is NTRB trading relative to its 50-day, 200-day, and 52-week technical levels?

NTRB last traded at $6.41 (+1.75% on volume of 14,755 shares), positioning the stock -0.16% below its 50-day simple moving average ($6.42) and +46.01% above its 200-day simple moving average ($4.39). Across its 52-week range of $2.80 to $9.19, NTRB sits at the 56.5% percentile with a 14-day RSI of 49.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($5.61 to $7.21).

Direct Sub-Reports: NTRB RQD Cockpit NTRB 12M Forecast NTRB Earnings & Move NTRB Dividends & DRIP NTRB Insiders & 13F NTRB Whale Options NTRB Profit Sankey NTRB News & Why

ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

NTRB — Nutriband Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:45:00Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

NTRB scores 39 out of 100, earning a letter grade of D- and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 4 of 20 (ROIC of -35%; FCF yield of -6.37%), Whale 13F Flow at 11 of 20 (institutional accumulation and options positioning), Insider Conviction at 3 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 10 of 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 11 of 20 (Altman Z 2.5; Piotroski F 4/9; Debt/Equity 0.5).

For a prospective investor, the weakest pillars are the cash engine and insider conviction. The Forensic Balance Sheet pillar sits in a middle range, which suggests the company is not in acute distress on the metrics provided but is not in a strong position either. The insider pillar, scored low, indicates limited evidence of insider conviction in the source data. This is an analytical summary, not personalized financial advice.

2. Business Model, Unit Margins & SEC Financial Trajectory

Nutriband Inc. (NTRB) is a NASDAQ-listed operating company in the Industrial Specialties industry (Health Care sector) with an equity market capitalization of $76.6M. The business operates with a gross margin of 27.8%, an operating margin of -60%, and a return on invested capital (ROIC) of -35% (free cash flow yield of -6.37%). Within the Industrial Specialties peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

Revenue has been roughly flat across the three reported periods while operating losses are substantial relative to revenue. Per the market data, gross margin is 27.8%, while operating and net margins are both -60% and ROIC is -35%. The Altman Z-Score is 2.5 and the Piotroski F-Score is 4 of 9, and Debt/Equity is 0.5. Cash is reported at $4.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case: Revenue has held near $2.0M–$2.1M across three periods while cash of $4.6M and a Piotroski F-Score of 4/9 show the balance sheet is not in acute distress. With Fundamental Cash Engine at 4/20 (ROIC -35.0%, FCF yield -6.37%) and Institutional Whale Flow at 10/20, sustained execution supports upside toward the top of the $2.80 – $9.19 52-week range.
🐻 Primary Bear Case: Operating margin of -60% and ROIC of -35% with negative FCF of -$5.1M in FY 2025 show the business is consuming cash rather than generating returns. Investors must weigh current valuation against -60.0% operating margins and a 1.00 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies, sector correlations, or second-order links are mapped in the source data. —

Key Question #1: What specific products or services generate the $2.0M in FY 2025 revenue, and who are the customers?
Key Question #2: What is the total debt balance, given that debt is listed as N/A across all reported periods?
Key Question #3: What is the basis for the $4.6M cash balance and how long does it fund the reported FCF burn of -$5.1M?

NTRB Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Nutriband Inc. (NTRB) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to NTRB Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 20h ago

Nutriband Inc. Estimates – NASDAQ:NTRB

TradingView report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 23h ago

Nutriband Inc. (NTRB) Seasonal Returns Chart

Yahoo! Finance Canada report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GlobeNewswire • 1d ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274

GlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 1d ago

(NTRB) Risk Channels and Responsive Allocation

Stock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Traders Daily • 1d ago

The Technical Signals Behind (NTRB) That Institutions Follow

Stock Traders Daily report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH www.siam.in • 1d ago

Nutriband Warrant (NTRBW) Sinks 68.21% to $0.55 as Leverage Cuts Both Ways - Call Dominated

www.siam.in report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GlobeNewswire • 1d ago

Nutriband Files New Patent Application to Strengthen

GlobeNewswire report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST https://www.dars.gov.et/ • 1d ago

NTRB Q3 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus by a Wide Margin - Earnings Decline Risk

https://www.dars.gov.et/ report covering Nutriband Inc. (NTRB) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NTRB Bull vs. Bear Conversation Board — What's Your Call at $6.41?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NTRB 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull Growth & Tech Investor 🐂 BULLISH 🎯 Target: $7.88 (+25.1%)

📌 Pinned Debate

Revenue has held near $2.0M–$2.1M across three periods while cash of $4.6M and a Piotroski F-Score of 4/9 show the balance sheet is not

Don't sleep on NTRB's setup in Health Care. Revenue has held near $2.0M–$2.1M across three periods while cash of $4.6M and a Piotroski F-Score of 4/9 show the balance sheet is not in acute distress.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (37/100) backs up the fundamental quality.

EarningsSniper 🐂 BULL

@ForensicBear Shorting a 10/20 institutional whale-flow stock at $6.30 is dangerous when funds are rotating into Health Care.

FO ForensicBear 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $4.72 (-25.1%)

Spot @ $6.30

Operating margin of -60% and ROIC of -35% with negative FCF of -$5.1M in FY 2025 show the business is consuming cash rather than genera

Sitting on the sidelines or leaning short NTRB above $6.30. Operating margin of -60% and ROIC of -35% with negative FCF of -$5.1M in FY 2025 show the business is consuming cash rather than generating returns.. Until Fundamental Cash Engine (4/20) and FCF yield (-6.37%) inflect higher, upside is capped near $9.19.